5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. It was first identified by the EMCDDA in February 2015
SGT-263
€179.00 – €2,990.00
| IUPAC name | 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)pyrrolo[2,3-b]pyridine-3-carboxamide |
|---|---|
| CAS Number | 2171492-36-5 |
| Formula | C22H26FN3O |
| Molar mass | 367.468 g·mol−1 |
Reviews
There are no reviews yet.